These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 20547804

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms.
    Yang SJ, Nast CC, Mishra NN, Yeaman MR, Fey PD, Bayer AS.
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3079-85. PubMed ID: 20498310
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Telavancin Is Active against Experimental Aortic Valve Endocarditis Caused by Daptomycin- and Methicillin-Resistant Staphylococcus aureus Strains.
    Abdelhady W, Bayer AS, Gonzales R, Li L, Xiong YQ.
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872064
    [Abstract] [Full Text] [Related]

  • 6. Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant Staphylococcus aureus: In Vitro, Ex Vivo, and In Vivo Metrics.
    Mishra NN, Lew C, Abdelhady W, Lapitan CK, Proctor RA, Rose WE, Bayer AS.
    Antimicrob Agents Chemother; 2022 Jan 18; 66(1):e0164921. PubMed ID: 34694870
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
    Werth BJ, Barber KE, Ireland CE, Rybak MJ.
    Antimicrob Agents Chemother; 2014 Jun 18; 58(6):3177-81. PubMed ID: 24663016
    [Abstract] [Full Text] [Related]

  • 8. The Role of mprF Mutations in Seesaw Effect of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Isolates.
    Jiang S, Zhuang H, Zhu F, Wei X, Zhang J, Sun L, Ji S, Wang H, Wu D, Zhao F, Yan R, Yu Y, Chen Y.
    Antimicrob Agents Chemother; 2022 Jan 18; 66(1):e0129521. PubMed ID: 34662187
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
    Steed ME, Vidaillac C, Rybak MJ.
    Antimicrob Agents Chemother; 2010 Dec 18; 54(12):5187-92. PubMed ID: 20921318
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.
    García-de-la-Mària C, Gasch O, García-Gonzalez J, Soy D, Shaw E, Ambrosioni J, Almela M, Pericàs JM, Tellez A, Falces C, Hernandez-Meneses M, Sandoval E, Quintana E, Vidal B, Tolosana JM, Fuster D, Llopis J, Pujol M, Moreno A, Marco F, Miró JM.
    Antimicrob Agents Chemother; 2018 Jun 18; 62(6):. PubMed ID: 29610194
    [Abstract] [Full Text] [Related]

  • 15. Daptomycin in Combination with Ceftolozane-Tazobactam or Cefazolin against Daptomycin-Susceptible and -Nonsusceptible Staphylococcus aureus in an In Vitro, Hollow-Fiber Model.
    Smith JR, Arya A, Yim J, Barber KE, Hallesy J, Singh NB, Rybak MJ.
    Antimicrob Agents Chemother; 2016 Jul 18; 60(7):3970-5. PubMed ID: 27090172
    [Abstract] [Full Text] [Related]

  • 16. Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics.
    Berti AD, Wergin JE, Girdaukas GG, Hetzel SJ, Sakoulas G, Rose WE.
    Antimicrob Agents Chemother; 2012 Oct 18; 56(10):5046-53. PubMed ID: 22802248
    [Abstract] [Full Text] [Related]

  • 17. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Miró JM, García-de-la-Mària C, Armero Y, Soy D, Moreno A, del Río A, Almela M, Sarasa M, Mestres CA, Gatell JM, Jiménez de Anta MT, Marco F, Hospital Clinic Experimental Endocarditis Study Group.
    Antimicrob Agents Chemother; 2009 Oct 18; 53(10):4172-7. PubMed ID: 19620326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea.
    Nam EY, Yang SJ, Kim ES, Cho JE, Park KH, Jung SI, Yoon N, Kim DM, Lee CS, Jang HC, Park Y, Lee KS, Kwak YG, Lee JH, Park SY, Hwang JH, Kim M, Song KH, Kim HB.
    Microb Drug Resist; 2018 Jun 18; 24(5):534-541. PubMed ID: 29863982
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.